Black pepper and its major component, piperine, can effectively regulate anemia of inflammation by reducing the overexpression of hepcidin, a hormone that controls iron levels.
Experimental Study Anaemia Black Pepper Hepcidin
The study involves a two-tier investigation, first in vitro, and then in vivo. In the laboratory, different black pepper extracts were interacted with a human liver cell line known as HepG2, and the one derived from methanol (BPME) showed the most promising result because it reduced the transcription of the hepcidin gene significantly. In addition to BPME, piperine was proven to almost entirely suppress hepcidin protein expression at specific concentrations.
In the subsequent in vivo experimentation, live mice were artificially induced with an elevated level of hepcidin through oil of turpentine injections. Then they were administered with BPME and piperine, the effects of which significantly reduced the enhanced hepcidin expression. The molecular interaction studies further suggest that piperine directly binds with SMAD1 and STAT3 proteins, the critical factors behind the overexpression of hepcidin.
The study found a demonstrable downregulation in hepcidin expression with the use of both the methanol extract of black pepper and the bioactive alkaloid piperine. These substances also interacted with some proteins to lower the overexpression of hepcidin initiated by inflammation. Additionally, there was a noticeable increase in iron bioavailability in the liver of treated test animals, pointing to the potential of these compounds to rectify anemia of inflammation. The findings posited black pepper as a possible therapeutic option for managing this anemic condition.
View Article